Three-dimensional bioprinted tissues composed of cells and other body-compatible materials have emerged as a powerful tool to repair damaged heart tissue. However, most bioprinted tissues cannot ...
Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics
VANCOUVER, British Columbia — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, today announced that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback